Neoleukin Therapeutics, Inc.

Neoleukin Therapeutics, Inc.verified

NLTX

Price:

$3.49

Market Cap:

$8.20M

Neoleukin Therapeutics, Inc., a biopharmaceutical company, develops immunotherapies for cancer, inflammation, and autoimmunity disorders using protein design technology. The company's lead product candidate is NL-201, a de novo protein designed to mimic the therapeutic activity of the cytokines interleukin (IL)-2/IL-15 for the treatment of various types of cancer, including renal cell carcinoma and melanoma. The company was formerly known as Aquinox Pharmaceuticals, Inc. and changed its name to Neoleukin Therapeutics, Inc. in August 2019. Neoleukin Therapeutics, Inc. was founded in 2003 and is headquartered in Seattle, Washington.[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2014-03-07

Stock Exchange

NASDAQ

Ticker

NLTX

The PE Ratio as of December 2024 (TTM) for Neoleukin Therapeutics, Inc. (NLTX) is -0.28

According to Neoleukin Therapeutics, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.28. This represents a change of -96.86% compared to the average of -9.05 of the last 4 quarters.

Neoleukin Therapeutics, Inc. (NLTX) Historical PE Ratio (quarterly & annually)

How has NLTX PE Ratio performed in the past?

The mean historical PE Ratio of Neoleukin Therapeutics, Inc. over the last ten years is -28.84. The current -0.28 PE Ratio has changed -1.47% with respect to the historical average. Over the past ten years (40 quarters), NLTX's PE Ratio was at its highest in in the December 2013 quarter at 193.38. The PE Ratio was at its lowest in in the June 2019 quarter at -54842.06.

Quarterly (TTM)
Annual

Average

-28.84

Median

-20.58

Minimum

-117.12

Maximum

-2.01

Neoleukin Therapeutics, Inc. (NLTX) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Neoleukin Therapeutics, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 510.52%

Maximum Annual PE Ratio = -2.01

Minimum Annual Increase = -88.95%

Minimum Annual PE Ratio = -117.12

Quarterly (TTM)
Annual
YearPE RatioChange
2022-2.01-88.95%
2021-18.17-84.49%
2020-117.12510.52%
2019-19.18198.18%
2018-6.43-70.73%
2017-21.98-34.81%
2016-33.7216.84%
2015-28.86164.39%
2014-10.92-63.67%
2013-30.0430.52%

Neoleukin Therapeutics, Inc. (NLTX) Average PE Ratio

How has NLTX PE Ratio performed in the past?

The current PE Ratio of Neoleukin Therapeutics, Inc. (NLTX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-45.77

5-year avg

-32.58

10-year avg

-28.84

Neoleukin Therapeutics, Inc. (NLTX) PE Ratio vs. Peers

How is NLTX’s PE Ratio compared to its peers?

Neoleukin Therapeutics, Inc.’s PE Ratio is less than CytomX Therapeutics, Inc. (6.74), less than Spero Therapeutics, Inc. (16.98), greater than Instil Bio, Inc. (-1.81), greater than NextCure, Inc. (-0.46), greater than Assembly Biosciences, Inc. (-2.30), greater than Achilles Therapeutics plc (-0.59), greater than Nuvation Bio Inc. (-1.36),

Build a custom stock screener for Neoleukin Therapeutics, Inc. (NLTX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Neoleukin Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Neoleukin Therapeutics, Inc. (NLTX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Neoleukin Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Neoleukin Therapeutics, Inc.'s PE Ratio?

How is the PE Ratio calculated for Neoleukin Therapeutics, Inc. (NLTX)?

What is the highest PE Ratio for Neoleukin Therapeutics, Inc. (NLTX)?

What is the 3-year average PE Ratio for Neoleukin Therapeutics, Inc. (NLTX)?

What is the 5-year average PE Ratio for Neoleukin Therapeutics, Inc. (NLTX)?

How does the current PE Ratio for Neoleukin Therapeutics, Inc. (NLTX) compare to its historical average?